TFAP4 Antilichaam - C-terminal regio : HRP (ARP33435_T100-HRP)

Transcription factor AP-4 (activating enhancer binding protein 4)

AP-4, bHLHc41

7023

Q01664

NP_003214

Human, Mouse, Rat, Dog, Guinea Pig, Horse, Rabbit

The immunogen is a synthetic peptide directed towards the C terminal region of human TFAP4

TFAP4 acts in concert with AP-1 to activate SV40 late transcription in vitro.

GOLGA2; TRAF1; FBXW11; EXOSC8; BTRC; CUL1; UBC; SKP1; SRP54; XRCC5; SP1; SOGA3; INO80E; ARID2; DNTTIP1; UHRF2; ELMSAN1; NAV3; EHMT1; SAP130; PRDM16; ZNF335; WIZ; ZNF462; MTA3; YEATS2; PPP6R3; C4orf27; TERF2IP; CHRAC1; ZBTB7A; ZBTB7B; TFCP2L1; BRD7; THYN1

HRP: Horseradish Peroxidase

Polyclonal Antibody

IHC, WB

TFAP4 is supported by BioGPS gene expression data to be expressed in HepG2

0.5 mg/ml

Dog: 86%; Guinea Pig: 93%; Horse: 86%; Human: 100%; Mouse: 93%; Rabbit: 79%; Rat: 93%

Liquid. Purified antibody is supplied in high phosphate PBS, 100 mm phosphate, 150 mM NaCl, pH 7.6.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

39kDa

Petersenn, S., et al., (1998) Mol. Endocrinol. 12 (2), 233-247

Wet Ice

338

TFAP4

TFAP4

Rabbit

Transcription factor AP-4

NM_003223

TSRQNLDTIVQAIQHIEGTQEKQELEEEQRRAVIVKPVRSCPEAPTSDTA